Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm

Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm

Source: 
Endpoints
snippet: 

A Massachusetts federal judge on Wednesday dismissed a class action lawsuit filed by investors against Biogen and several of its current and former executives over the company’s failed Alzheimer’s drug, Aduhelm (aducanumab).